Multiscale modeling to optimize inhibition of oncogenic ERK pathway signaling

Ended Project Grant Awarded Last action

Award ID
R01CA244660
Recipient
Awarding agency
Obligated
$8,765,235

Award facts

Assistance listing
93.395 Cancer Treatment Research
Completion date
Funding
  • $8,071,893.00 Federal
  • $693,342.00 Non-federal
Place of performance
Connecticut, USA

Award details come from USAspending.gov.

Transactions

Action Federal Non-federal Date
Amendment $0 $0
Amendment $33,876 $0
Amendment $33,876 $0
Amendment $609,800 $0
Amendment $609,800 $0
Amendment $609,800 $0
Amendment $669,574 $0
Amendment $669,574 $0
Amendment $669,574 $0
Amendment $55,055 $0
Amendment $55,055 $0
Amendment $619,367 $0
Amendment $619,367 $0
Amendment $693,342 $0
Amendment $693,342 $0
Amendment $693,342 $693,342
Original award $737,149 $0
Show all 17

Subawards

Subrecipient Amount Awarded
University College Dublin Specific Aim 1: Determine how kinase conformation selectivity of RAF, MEK and ERK inhibitors affects their ability to suppress ERK signaling using multiscale… $19,117
University College Dublin Specific Aim 1: Determine how kinase conformation selectivity of RAF, MEK and ERK inhibitors affects their ability to suppress ERK signaling using multiscale… $172,056
The Trustees Of The University Of Pennsylvania Multiscale Modeling to Optimize Inhibition of Oncogenic ERK Pathway Signaling Clinical use of RAF, MEK and ERK inhibitors does not result in durable… $103,089

Quick answers

Who received award R01CA244660?

R01CA244660 was awarded to Yale Univ by National Cancer Institute (National Institutes of Health) on February 7, 2020.

How much is award R01CA244660 worth?

$8,765,235 has been obligated on R01CA244660: $8,071,893 in federal funding and $693,342 in non-federal funding.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award